Items | Units | At diagnosis | At last follow-up | Test; P value |
---|---|---|---|---|
Age: mean (SD) | years | 38.6 (19.7) | 46.8 (18.7) | |
Time interval: m(SD) | years | 3.6 (8.1) | 8.2 (7.2) | |
Gross Haematuria: | N (%) | 29 (39.2%) | 29 (39.2%) | |
Proteinuria: | ||||
Mean (SD): | g/d | 1.29 (1.56) | 0.43 (0.68) | T = −4.8; <0.0001 |
Median (extremes): | g/d | 0.80 (0.00-10.00) | 0.18 (0.00-3.66) | |
Class (g/d): | ||||
<0.30 or absent | N (%) | 20 (27.0%) | 44 (59.5%) | |
0.30–0.99 | N (%) | 22 (29.7%) | 21 (28.4%) | X2 = 15.0; NS (0.09) |
1.00–2.99 | N (%) | 19 (25.7%) | 7 (9.5%) | |
≥ 3.00 | N (%) | 13 (17.6%) | 2 (2.7%) | |
Proteinuria ≥1 g/d | N (%) | 32 (43.2%) | 9 (12.2%) | |
Hypertension: yes | N (%) | 29 (39.2%) | 49 (66.2%) | X2 = 24.3; <0.0001 |
SBP in HT + ve: m (SD) | mm Hg | 140.2 (16.9) | 139.5 (17.2) | |
SBP in HT-ve: m (SD) | mm Hg | 128.4 (19.0) | 120.2 (15.7) | |
DBP in HT + ve: m (SD) | mm Hg | 84.8 (13.5) | 82.9 (9.2) | |
DBP in HT-ve: m (SD) | mm Hg | 75.8 (12.5) | 76.6 (10.0) | |
Pathology/GOS (0–20): | ||||
Mean (SD) | units | 7.17 (2.75) | / | |
Median (range) | units | 7.00 (2–16) | / | |
GOS ≥ 8 | N (%) | 30 (40.5%) | / | |
GVTI indices: m (SD) | G = 3.38 (1.40) | V = 1.95 (1.06) | T = 0.87 (0.68) | I = 0.97 (0.74) |
End-point/eGFR: | ||||
Mean (SD) | ml/mn/1.73 m2 S | 82.2 (34.0) | 60.0 (35.2) | T = 6.3;<0.0001 |
Median (extremes) | ml/mn/1.73 m2 S | 85.3 (7.1-200.4) | 68.7 (5.8-147.0) | |
eGFR staging: | ||||
Stage 1: ≥ 90 | N (%) | 30 (40.5%) | 14 (18.9%) | |
Stage 2: 60–89 | N (%) | 27 (36.5%) | 33 (44.6%) | |
Stage 3: 30–59 | N (%) | 11 (14.9%) | 9 (12.2%) | X2 = 60.3; <0.0001 |
Stage 4: 15–29 | N (%) | 3 (4.1%) | 2 (2.7%) | |
Stage 5: <15 | N (%) | 3 (4.1%) | 16 (21.6%) | |
CKD-3+ (eGFR < 60) | N (%) | 17 (23.0%) | 27 (36.5%) | X2 = 25.5; <0.0001 |
Dialysis | N (%) | 2 (2.7%) | 15 (20.3%) | |
Death | N (%) | 0 (0.0%) | 4 (5.4%) | |
Dialysis/Death | N (%) | 2 (2.7%) | 19 (25.7%) | X2 = 6.0; =0.01 |